Search

everythinglearnresearchcommunity

for

Search:↓

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

New compounds may help treat prostate issues without affecting androgen receptors.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Cortisone reductase deficiency can cause high androgen and cortisol levels and may be missed in women with similar symptoms.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

The effects of estrogen on human scalp hair growth are unclear and need more research.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Certain drugs that block specific enzymes can help treat prostate diseases.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Finasteride effectively treats BPH, but needs more trials to understand potential.

High doses of cyclosporine A increase testosterone conversion, possibly boosting hair growth.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Hereditary hyperplastic gingivitis in silver foxes may be linked to errors in the MAPK signaling pathway, influenced by androgens.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.